Navigation Links
Glaucoma medications may be associated with reduced risk of death over 4-year period

Glaucoma patients who take medication for the condition appear to have a reduced likelihood of death, according to a report in the February issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

Glaucoma (a common condition that consists of elevated pressure in the eye, and that can lead to loss of vision) usually affects older adults, who are at risk for co-existing medical conditions that can negatively affect their survival, according to background information in the article. "In recent years, numerous studies have assessed whether glaucoma is associated with mortality," the authors write. "Few studies, however, have considered whether the medications commonly used to treat glaucoma may affect the association between glaucoma and death."

Joshua D. Stein, M.D., M.S., and colleagues at the University of Michigan, Ann Arbor, conducted a study evaluating the relationship between glaucoma medication use and death in 21,506 individuals age 40 or older (average age 60) with glaucoma or suspected glaucoma from January 2003 to December 2007 who were enrolled in a large managed care network. Glaucoma medication use was defined as filling one or more prescriptions for a 30-day or more supply of the drug during the study period. Deaths were reported by family members, employers or health care professionals and other demographic information was noted at the beginning of the study.

More than half of the patients had suspected glaucoma, the others had one or more types of glaucoma. "During the study period, 6,049 beneficiaries (28.1 percent) filled one or more prescriptions for a glaucoma medication; 2,021 individuals (9.4 percent) underwent glaucoma surgery," the authors write.

Of the 21,506 patients, 237 (1.1 percent) died during the study. When compared to those with no glaucoma medication use, those using any class of glaucoma medication had a 74 percent reduced risk of death. "This association was observed for use of a single agent alone, such as a topical beta-antagonist or a prostaglandin analogue, and for use of different combinations of drug classes," the authors write.

"Additional studies are needed to determine whether this result is best explained by a protective effect of the medications themselves or by other confounding factors, such as access to care or providers' prescribing patterns," the authors conclude. "Future investigations should explore this association further because these findings may have important clinical implications."


Contact: Betsy Nisbet
JAMA and Archives Journals

Related medicine news :

1. Glaucoma Drugs May Play Role in Longer Life
2. Luis Tiant and Sunridge International Partner to Provide Medical Relief in Cuba: Former Star Pitcher for the Red Sox and Yankees Leads the Fight Against Glaucoma
3. DR Vitamins, LLC Introduces Vision Clarity Carnosine Eye Drops to Treat Cataracts, Glaucoma, Dry Eye, or Other Eye Ailments
4. January is Glaucoma Awareness Month
5. Refinement of glaucoma testing, treatment expected from US, United Kingdom study
6. AUDIO from Medialink and Pfizer: Glaucoma - The Sneak Thief of Sight
7. Treating ROP in tiny preemies; better glaucoma follow-up in urban clinic
8. Toronto researchers discover novel circulation in human eye, new glaucoma treatment target
9. Glaucoma Tied to Gene Variants in Blacks
10. OcumatRx Announces Promising Clinical Trial Results for Implant with Potential to Permanently Treat Glaucoma
11. Quark Pharmaceuticals Announces Data Indicating Potential Utility of QPI-1007 for Treatment of Glaucoma
Post Your Comments:
(Date:11/24/2015)... Angeles, CA (PRWEB) , ... November 24, 2015 , ... ... explored the different restrictions and variables that determine which patients are or are not ... those patients that have a BMI over 40, are more than 100 pounds overweight, ...
(Date:11/24/2015)... City, UT (PRWEB) , ... November 24, 2015 , ... ... Forbes Magazine. For a business, it is critical that the first impression be positive ... business, they are not likely to buy anything or want to return. They will ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... share their knowledge and experiences at a live taping of the next ... for the Cure of Gastrointestinal Cancers 2015 Symposium at Georgetown University Hotel & ...
(Date:11/24/2015)... ... ... Aided by seed funding from the Ron Foley Foundation, researchers at Western Connecticut ... to detect and treat pancreatic cancer (PC). , WCHN researchers will focus on ... genetic material that is present in the blood of patients with PC. It ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... award for its exceptional customer service: the TrustDale certification. The award recognizes good ... Baltimore stone honing , tile and grout, and hard surface restoration company ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015 Avery Biomedical ... is pleased to announce the appointment of Anders ... Dr. Jonzon ... cardiology at Children,s Hospital, Uppsala University, Uppsala and Children,s ... 1984-1986, he was a fellow at the Cardiovascular Institute ...
(Date:11/24/2015)... and BERN, Switzerland , November ... ARTORG Center for Biomedical Engineering Research of the University ... Division of Endocrinology, Diabetes and Clinical Nutrition of the ... start of an exclusive collaboration to develop a novel ... for the personalised delivery of insulin for diabetic patients ...
(Date:11/24/2015)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that ... and Human Resources will be presenting in the upcoming Atlantic ... Strategies for a Dynamic Market" on Dec. 1, 2015. Rice ... with the Cambridge Advisory Group, where she leads their pharmacy ... webinar will discuss the rapid growth of oral oncolytics, the ...
Breaking Medicine Technology: